News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Is AbbVie (ABBV) Already Making a Recall?


1/14/2013 7:30:31 AM

AbbVie Inc., the Abbott Laboratories spinoff, has recalled more than 28,520 bottles of the thyroid-hormone replacement therapy Synthroid over a labeling error. It is the second recall of the drug in six months. Synthroid is a synthetic thyroid hormone used to treat hypothyroidism, when the thyroid gland doesn't produce enough natural thyroid hormone. One lot of 150-microgram Synthroid tablets was recalled because a bottle was found to contain a lower dose, AbbVie spokesman Greg Miley said Friday. The voluntary recall began in early December, when AbbVie was still part of Abbott. The company said it was due to a manufacturing error and has taken corrective action. AbbVie isn't aware of any increase in patient complaints or adverse events associated with the error.



comments powered by Disqus
AbbVie
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES